Exploring the Therapeutic Potential of LIMK1/2 Inhibitors in Amyotrophic Lateral Sclerosis: Targeting Actin Dynamics via Cofilin Modulation

Cyril Jones Jagaraj

Presentation information

Oral

[1O01e] Neurological diseases 1

Wed. Jul 24, 2024 5:00 PM - 6:00 PM Room 1 (Main Hall)

Chairperson: Koji Yamanaka (Nagoya University, Reserach Institute of Environmental Medicine), Atsushi Sugie (Brain Research Institute, Niigata University)

[1O01e-02] Exploring the Therapeutic Potential of LIMK1/2 Inhibitors in Amyotrophic Lateral Sclerosis: Targeting Actin Dynamics via Cofilin Modulation

*Cyril Jones Jagaraj¹, Angela Laird¹, Julie Atkin^1,2 (1. MND Research Centre, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, 2. La Trobe Institute for Molecular Science, La Trobe University)

Keywords:ALS, Actin dysregulation , novel therapy, mouse pre-clinical studies

Please log in with your participant account.
» Participant Log In